What is Kestrel Therapeutics worth?
$17.7Mlast known valuation
Kestrel Therapeutics last raised $5.0M in its Early Stage VC (Jul 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Kestrel Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2025 | Early Stage VC | $5.0M | ▮ | ▮ |
| Feb 2025 | Early Stage VC | $8.0M | ▮ | ▮ |
| Dec 2021 | Early Stage VC | $7.5M | ▮ | ▮ |
How Kestrel Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Kestrel Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Kestrel Therapeutics worth?
- Kestrel Therapeutics's last known valuation is $17.7M.
- How much has Kestrel Therapeutics raised?
- Kestrel Therapeutics has raised $20.7M in total funding across 3 recorded rounds.
- When did Kestrel Therapeutics last raise?
- Kestrel Therapeutics last raised in Jul 2025 (Early Stage VC), raising $5.0M.